PubMed PMID: 11735244
A tiny drop of blood or clear fluid at the puncture site indicates normal needle withdrawal
Key takeaways: 27% of respondents noticed changes to their menstrual cycle since starting GLP-1 medication for weight loss Respondents with PCOS were more likely to experience cycle changes, and 43% of this group reported noticing changes to their menstrual cycle The most commonly reported cycle changes were more predictable periods, more frequent periods, and shorter periods GLP-1 medications like semaglutide (Ozempic) and tirzepatide (Mounjaro) have traditionally been used to treat diabetes
Youre likely familiar with semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA) used in commercially available prescription medicines for treatment of type 2 diabetes and obesity
Ping Y, Shan J, Qin H, Li F, Qu J, Guo R, et al
By combining primary care, pharmacy services, and logistics, Amazon is positioning weight management as a continuous treatment journey, potentially reshaping how patients access and adhere to GLP-1 therapies